Business Description
Enveric Biosciences Inc
NAICS : 541714
SIC : 2834
ISIN : US29405E2081
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 228.8 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.01 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 46.7 | |||||
3-Year EPS without NRI Growth Rate | 47.6 | |||||
3-Year FCF Growth Rate | 42.4 | |||||
3-Year Book Growth Rate | -65.1 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 22.78 | |||||
9-Day RSI | 32.54 | |||||
14-Day RSI | 38.25 | |||||
6-1 Month Momentum % | -31.64 | |||||
12-1 Month Momentum % | -37.2 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.53 | |||||
Quick Ratio | 1.53 | |||||
Cash Ratio | 0.98 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -138.5 | |||||
Shareholder Yield % | 1.35 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -252.02 | |||||
ROA % | -154.22 | |||||
ROIC % | -777.79 | |||||
ROC (Joel Greenblatt) % | -2952.09 | |||||
ROCE % | -249.94 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.18 | |||||
Price-to-Tangible-Book | 1.24 | |||||
EV-to-EBIT | 0.06 | |||||
EV-to-EBITDA | 0.06 | |||||
EV-to-FCF | 0.07 | |||||
Price-to-Net-Current-Asset-Value | 1.77 | |||||
Earnings Yield (Greenblatt) % | 1733.86 | |||||
FCF Yield % | -236.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Enveric Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -7.53 | ||
Beta | -1.41 | ||
Volatility % | 207.2 | ||
14-Day RSI | 38.25 | ||
14-Day ATR (€) | 0.055186 | ||
20-Day SMA (€) | 0.83605 | ||
12-1 Month Momentum % | -37.2 | ||
52-Week Range (€) | 0.671 - 4.225 | ||
Shares Outstanding (Mil) | 7.29 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Enveric Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Enveric Biosciences Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Enveric Biosciences Inc Frequently Asked Questions
What is Enveric Biosciences Inc(STU:SLZA)'s stock price today?
When is next earnings date of Enveric Biosciences Inc(STU:SLZA)?
Does Enveric Biosciences Inc(STU:SLZA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |